Exencial Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.29M | Buy |
21,285
+17
| +0.1% | +$991 | 0.04% | 266 |
|
|
2025
Q4 | $1.15M | Buy |
21,268
+5,593
| +36% | +$269K | 0.04% | 276 |
|
|
2025
Q3 | $707K | Sell |
15,675
-329
| -2% | -$15.4K | 0.02% | 327 |
|
|
2025
Q2 | $741K | Hold |
16,004
| – | – | 0.03% | 323 |
|
|
2025
Q1 | $976K | Sell |
16,004
-772
| -5% | -$45K | 0.04% | 281 |
|
|
2024
Q4 | $949K | Buy |
16,776
+1,353
| +9% | +$75.6K | 0.03% | 287 |
|
|
2024
Q3 | $798K | Sell |
15,423
-3,814
| -20% | -$179K | 0.03% | 299 |
|
|
2024
Q2 | $799K | Sell |
19,237
-879
| -4% | -$39.3K | 0.03% | 298 |
|
|
2024
Q1 | $1.09M | Sell |
20,116
-2,556
| -11% | -$130K | 0.04% | 267 |
|
|
2023
Q4 | $1.16M | Sell |
22,672
-3,853
| -15% | -$202K | 0.05% | 245 |
|
|
2023
Q3 | $1.54M | Sell |
26,525
-736
| -3% | -$45.1K | 0.07% | 200 |
|
|
2023
Q2 | $1.74M | Buy |
27,261
+15,267
| +127% | +$1.02M | 0.08% | 190 |
|
|
2023
Q1 | $831K | Buy |
11,994
+234
| +2% | +$16.5K | 0.04% | 235 |
|
|
2022
Q4 | $846K | Buy |
11,760
+3,512
| +43% | +$265K | 0.05% | 233 |
|
|
2022
Q3 | $586K | Sell |
8,248
-290
| -3% | -$21K | 0.04% | 255 |
|
|
2022
Q2 | $657K | Sell |
8,538
-4,153
| -33% | -$316K | 0.04% | 255 |
|
|
2022
Q1 | $927K | Sell |
12,691
-5,636
| -31% | -$378K | 0.05% | 242 |
|
|
2021
Q4 | $1.14M | Sell |
18,327
-9,822
| -35% | -$576K | 0.06% | 222 |
|
|
2021
Q3 | $1.67M | Buy |
28,149
+4,242
| +18% | +$279K | 0.07% | 159 |
|
|
2021
Q2 | $1.6M | Sell |
23,907
-355
| -1% | -$23.1K | 0.09% | 200 |
|
|
2021
Q1 | $1.53M | Sell |
24,262
-254,656
| -91% | -$15.8M | 0.09% | 187 |
|
|
2020
Q4 | $1.62M | Sell |
278,918
-88,753
| -24% | -$5.46M | 0.11% | 168 |
|
|
2020
Q3 | $7.33M | Buy |
367,671
+13,720
| +4% | +$826K | 0.39% | 76 |
|
|
2020
Q2 | $6.8M | Buy |
353,951
+76,864
| +28% | +$4.6M | 0.59% | 47 |
|
|
2020
Q1 | $15.4M | Buy |
277,087
+265,315
| +2,254% | +$16.2M | 2.76% | 5 |
|
|
2019
Q4 | $756K | Buy |
11,772
+3,620
| +44% | +$207K | 0.13% | 141 |
|
|
2019
Q3 | $413K | Buy |
8,152
+2,643
| +48% | +$124K | 0.09% | 167 |
|
|
2019
Q2 | $250K | Hold |
5,509
| – | – | 0.06% | 198 |
|
|
2019
Q1 | $263K | Buy |
5,509
+121
| +2% | +$6.03K | 0.06% | 190 |
|
|
2018
Q4 | $280K | Buy |
+5,388
| New | +$289K | 0.08% | 175 |
|
|
2018
Q3 | – | Sell |
-7,976
| Closed | -$441K | – | 193 |
|
|
2018
Q2 | $441K | Sell |
7,976
-181
| -2% | -$9.78K | 0.12% | 120 |
|
|
2018
Q1 | $516K | Sell |
8,157
-1,555
| -16% | -$100K | 0.15% | 111 |
|
|
2017
Q4 | $595K | Sell |
9,712
-697
| -7% | -$43.6K | 0.18% | 110 |
|
|
2017
Q3 | $663K | Buy |
10,409
+170
| +2% | +$9.93K | 0.22% | 97 |
|
|
2017
Q2 | $571K | Sell |
10,239
-876
| -8% | -$47.7K | 0.23% | 86 |
|
|
2017
Q1 | $591K | Sell |
11,115
-510
| -4% | -$28K | 0.26% | 82 |
|
|
2016
Q4 | $679K | Sell |
11,625
-98
| -0.8% | -$5.36K | 0.29% | 79 |
|
|
2016
Q3 | $597K | Sell |
11,723
-237
| -2% | -$15.2K | 0.26% | 83 |
|
|
2016
Q2 | $880K | Buy |
11,960
+3,107
| +35% | +$220K | 0.4% | 71 |
|
|
2016
Q1 | $566K | Sell |
8,853
-530
| -6% | -$33.4K | 0.27% | 83 |
|
|
2015
Q4 | $591K | Hold |
9,383
| – | – | 0.29% | 77 |
|
|
2015
Q3 | $555K | Hold |
9,383
| – | – | 0.27% | 83 |
|
|
2015
Q2 | $640K | Sell |
9,383
-327
| -3% | -$21.6K | 0.4% | 59 |
|
|
2015
Q1 | $618K | Sell |
9,710
-389
| -4% | -$24.4K | 0.26% | 90 |
|
|
2014
Q4 | $609K | Sell |
10,099
-70
| -0.7% | -$3.95K | 0.27% | 86 |
|
|
2014
Q3 | $520K | Buy |
10,169
+4
| +0% | +$200 | 0.23% | 96 |
|
|
2014
Q2 | $487K | Sell |
10,165
-973
| -9% | -$47.9K | 0.21% | 102 |
|
|
2014
Q1 | $547K | Sell |
11,138
-115
| -1% | -$6.12K | 0.23% | 101 |
|
|
2013
Q4 | $617K | Buy |
11,253
+8
| +0.1% | +$408 | 0.28% | 89 |
|
|
2013
Q3 | $591K | Sell |
11,245
-177
| -2% | -$7.77K | 0.28% | 91 |
|
|
2013
Q2 | $495K | Buy |
+11,422
| New | +$496K | 0.25% | 91 |
|
Other funds holding BMY
VCM
VPM
Exencial Wealth Advisors's BMY Position: Q1 2026 in Review
Exencial Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.08% in Q1 2026, buying an estimated $991 and bringing the position to 21,285 shares worth $1.29M. The position accounts for 0.04% of the portfolio, ranked #266.
Exencial Wealth Advisors first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $15.4M in Q1 2020. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Exencial Wealth Advisors held 21,285 shares of Bristol-Myers Squibb worth $1.29M as of Q1 2026.
- Exencial Wealth Advisors bought 17 Bristol-Myers Squibb shares in Q1 2026, an estimated $991.
- Bristol-Myers Squibb made up 0.04% of Exencial Wealth Advisors's portfolio in Q1 2026, its #266 holding.
- Exencial Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
- Exencial Wealth Advisors's Bristol-Myers Squibb position peaked at $15.4M in Q1 2020.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.